Clinical trials
Hemochromatosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
54 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 3 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 3 |
| 2010 | 1 |
| 2012 | 4 |
| 2013 | 4 |
| 2014 | 1 |
| 2015 | 4 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 36 |
| Unknown status | 6 |
| Recruiting | 4 |
| Terminated | 4 |
| Active, not recruiting | 2 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Rennes University Hospital | 8 |
| National Heart, Lung, and Blood Institute (NHLBI) | 5 |
| Novartis Pharmaceuticals | 3 |
| Bond Biosciences | 2 |
| Lipomed | 2 |
| Sanquin Research & Blood Bank Divisions | 2 |
| St. Jude Children's Research Hospital | 2 |
| University of Wisconsin, Madison | 2 |
| ApoPharma | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hemochromatosis | 54 |
| Iron Overload | 19 |
| Thalassemia | 8 |
| Hematologic Diseases | 5 |
| Anemia, Sickle Cell | 3 |
| beta-Thalassemia | 3 |
| Cholangitis, Sclerosing | 2 |
| Fibrosis | 2 |
| Hemosiderosis | 2 |
| Hepatitis, Autoimmune | 2 |
Trials
Showing 1 to 25 of 54. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.